AlgiPharma is a clinical stage biopharmaceutical company with a focus on developing its proprietary alginate technology for:
* Delivery platforms for nanoparticles, small and large molecule based drugs.
* Drug conjugates, adding functionality and reducing toxicity of parent compound.
* Stand alone API in disease areas such as cystic fibrosis, COPD, and infectious diseases.
AlgiPharma’s OligoG technology is based on highly purified and defined oligosaccharides processed and isolated from the alginate polysaccharide and manufactured according to GMP guidelines, ICH Q7 and ISO standards.